《港樓》錦上路站柏瓏II再沽7伙 單日套現逾6,000萬
信置(00083.HK)、中海外(00688.HK)、嘉華國際(00173.HK)與港鐵(00066.HK)合作發展,位於元朗錦上路站的柏瓏II最新再沽7伙,當中5伙為兩房單位,2伙為三房單位,項目單日套現逾6,000萬,平均成交呎價逾15,300元。項目11日累計售出77伙,套現近7億。
所有成交單位當中,最高成交價單位為8座3樓A3單位,三房間隔,實用面積832平方呎,成交價1,280.34萬元,呎價15,389元。
最高成交呎價單位為10座9樓B2單位,兩房間隔,實用面積451平方呎,成交價740.88萬元,呎價16,427元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.